Aguilar-Olivos NE, Balderas-Garcés B, Gómez-Gutiérrez C, Noffal-Nuno V, Méndez-Sánchez N

Language: English
References: 8
Page: 97-99
PDF size: 115.94 Kb.

ABSTRACT

Background. Recurrence of Clostridium difficile infection (CDI) is estimated between 5-50% and depends on several factors. Objective. To assess factors associated with recurrent CDI in a Mexican population. Material and methods. We analyzed the clinical records of all inpatients in our institution with CDI from 1 January 2012 to 30 April 2015. Recurrence was considered as a second positive test after 15 days of the initial positive test. We evaluated the factors associated with recurrence. Results. One hundred and sixty- seven inpatients with CDI were studied. We found recurrence of 8.4%. Among patients with recurrent CDI, 54% were in hospital treatment with an antibiotic and had higher Charlson index. Conclusion. In the studied population, the CDI recurrence rate was 8.4%. Antibiotic use and presence of comorbidities were associated with recurrence.

REFERENCES

1. Elliott B, Chang BJ, Golledge CL, Riley TV. Clostridium difficile associated diarrhoea. Intern Med 2007; 37: 561-8.

2. Hall AJ, Curns AT, McDonald LC, Parashar UD, Lopman BA. The roles of Clostridium difficile and norovirus among gastroenteritisassociated deaths in the United States, 1999-2007. Clin Infect Dis 2012; 55: 216-2

3. Banaei N, Anikst V, Schroeder LF. Burden of Clostridium difficile infection in the United States. N Engl J Med 2015; 372(24): 2368-9.

4. Deshpande A, Pasupuleti V, Thota P, Pant C, Rolston DD, Hernandez AV, Donskey CJ, et al. Risk factors for recurrent Clostridium difficile infection: a systematic review and meta-analysis. Infect Control Hosp Epidemiol 2015; 36(4): 452-60.

5. Abdelfatah M, Nayfe R, Nijim A, Enriquez K, Ali E, Watkins RR, Kandil H. Factors predicting recurrence of Clostridium difficile infection (CDI) in hospitalized patients: Retrospective study of more than 2000 patients. J Investig Med 2015; 63(5): 747-51.

6. Tleyjeh IM, Bin Abdulhak AA, Riaz M, Alasmari FA, Garbati MA, AlGhamdi M, Khan AR, et al. Association between proton pump inhibitor therapy and clostridium difficile infection: a contemporary systematic review and meta-analysis. PLoS One 2012; 7(12): e50836.

7. Zilberberg MD, Shorr AF, Micek ST, Kollef MH. Clostridium difficile recurrence is a strong predictor of 30-day rehospitalization among patients in intensive care. Infect Control Hosp Epidemiol 2015; 36(3): 273-9. Doi: 10.1017/ice.2014.47.

8. Camacho-Ortiz A, López-Barrera D, Hernández-García R, Galván- De los Santos AM, Flores-Treviño SM, Llaca-Díaz JM, et al. First Report of Clostridium difficile NAP1/027 in a Mexican Hospital. PLoS ONE 2015; 10(4): e0122627.